-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

907. Outcomes Research: Plasma Cell Disorders: Poster III

Symposia: Outcomes Research: Plasma Cell Disorders Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Feng Lin1*, Samy Gallienne2*, Raluca Ionescu-Ittu2*, Medha Sasane1*, Ani Minasyan1*, Christina Tekle1* and Joshua Richter, MD3

1Sanofi, Cambridge, MA
2STATLOG, Montreal, Canada
3Mount Sinai, New York, NY

Dawn Swan, MRCP, FRCPath1*, Marsali Maclean1*, Niamh Waters, MBBS2*, Denise Lee, MBBS2*, Charmaine Smith3*, Arina Martynchyk1*, Eliza A. Hawkes, MD4 and Jay Hocking, MBBS, FRACP, FRCPA, PhD1*

1Department of Clinical Haematology, Austin Health, Melbourne, VIC, Australia
2Austin Hospital, Melbourne, VIC, Australia
3Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Heidelberg, VIC, Australia
4Olivia Newton-John Cancer Research Institute, Melbourne, Australia

Anne-Valérie Keller, MSc1*, Marina Hajiyianni2*, Eileen Kurre1*, Elias Karl Mai, MD1,2*, Uta Bertsch, MD1,2,3*, Axel Benner4*, Steffen Luntz, MD5*, Marc-Steffen Raab1,2*, Britta Besemer, MD6*, Christian Sebastian Michel, MD7*, Roland Schroers, MD8*, Roland Fenk, MD, PhD9*, Hans Salwender, MD10*, Igor Wolfgang Blau, MD, PhD11*, Mathias Hänel, MD12, Christoph Mann, MD13* and Hartmut Goldschmidt, MD1,2,3

1Internal Medicine V, Hematology, Oncology and Rheumatology, GMMG Studygroup, Heidelberg University Hospital, Heidelberg, Germany
2Department of Medicine V, Heidelberg Myeloma Center, University Hospital Heidelberg, Heidelberg, Germany
3National Center for Tumor Diseases Heidelberg, Heidelberg, Germany
4Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
5Coordination Centre for Clinical Trials (KKS), Heidelberg, Germany
6Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany
7Department of Internal Medicine III, University Hospital Mainz, Mainz, Germany
8Medical Clinic, University Hospital Bochum, Bochum, Germany
9Department of Haematology, Oncology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany
10Asklepios Tumorzentrum Hamburg, Asklepios Hospital Hamburg Altona, Hamburg, Germany
11Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Berlin, Germany
12Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany
13Department of Haematology, Oncology and Immunology, Philipps-University Marburg, Marburg, Germany

Jeremie Zerbit, PharmD, PhD1*, Guillemette Fouquet, MD, PhD2*, Marion Detroit, PharmD, PhD3*, Sylvain Choquet, MD4*, Laurent Garderet5*, Olivier Hermine, MD, PhD6, Clarisse Cazelles, MD6*, Laurent Frenzel, MD, PhD6*, Mohamad Mohty, MD, PhD7, Zoe Van De Wyngaert, MD7*, Harel Stephanie, MD8*, Karim Belhadj Merzoug, MD, PhD9*, Sabine Brechignac, MD10*, Didier Bouscary, MD, PhD11*, Cyrielle Rodier, MD11*, Romain Winer, PharmD1*, Mathis Collier, PhD12* and Marguerite Vignon, MD11*

1Hospital at Home, Greater Paris University Hospitals (AP-HP), Paris, France
2Hematology, Hospital Sud Francilien, Corbeil-Essonnes, France
3Pharmacy, Pitie-Salpetriere Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
4Pitie-Salpetriere Hospital, Paris, France
5Hematology, Pitie-Salpetriere Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
6Hematology, Necker Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
7Hematology, Saint-Antoine Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
8Immuno-hematology, Saint-Louis Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
9Unit of Lymphoid Hemopathies, Henri Mondor Hospital, Greater Paris University Hospitals (AP-HP), Creteil, France
10Clinical Hematology, Avicenne Hospital, Greater Paris University Hospitals (AP-HP), Bobigny, France
11Hematology, Cochin Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
12Clinical Research Unit, Cochin Hospital, Greater Paris University Hospitals (AP-HP), Paris, France

Gabriel Najarro, PA-C, MMSc1*, Vikas A. Gupta, MD PhD2, Nisha S. Joseph, MD2, Jonathan L. Kaufman, MD2, Ajay K. Nooka, MD, MPH3, Madhav V. Dhodapkar, MD PhD2, Sagar Lonial, MD2* and Craig C. Hofmeister, MD4

1Emory University, Atlanta, GA
2Winship Cancer Institute of Emory University, Atlanta, GA
3Winship Cancer Institute of Emory University, Atlanta
4Emory Digital, Emory University, Atlanta, GA

Nadine Abdallah, MD1, Jay R. Hydren, PhD2, Mason S. Barnes, B.S.2*, Andrew Wood, BS2*, Sascha Alexander Tuchman, MD, MHS3, Jeffrey A. Zonder, MD 4, Giada Bianchi, MD5, Heather J. Landau, MD6, Muhamed Baljevic, MD7, James E. Hoffman8, Ana M. Sahagun Sanchez Aldana, MS2*, Jorge Arturo Hurtado Martinez, MD2*, Jennifer M. Ahlstrom, BA2* and Morie A. Gertz, MD9

1Mayo Clinic, Rochester, MN
2HealthTree Foundation, Lehi, UT
3University of North Carolina, Durham, NC
4Karmanos Cancer Institute, Detroit, MI
5Dana-Farber Cancer Institute, Boston, MA
6Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
8Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
9Division of Hematology, Mayo Clinic, Rochester, MN

Karen Sweiss, PharmD1, Jay R. Hydren, PhD2, Jorge Arturo Hurtado Martinez, MD2*, Mason S. Barnes, B.S.2*, Pritesh Patel, MD3*, Douglas W. Sborov, MD, MS4, Jennifer M. Ahlstrom, BA2*, Lisa Sharp, PhD, BSN, MA5* and Craig C. Hofmeister, MD6

1Department of Pharmacy Practice, University of Illinois at Chicago, Hinsdale, IL
2HealthTree Foundation, Lehi, UT
3Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
4University of Utah School of Medicine, Salt Lake City, UT
5University of Illinois at Chicago, Chicago, IL
6Winship Cancer Institute of Emory University, Atlanta, GA

Apoorva Doshi, MBBS1*, Gayathri Ravi, MD2, Susan Bal, MD2, Supriya Maheshwari, MBBS3*, Kelly Godby4*, Luciano J. Costa, MD, PhD2, Joshua Richman5*, Grant Williams, MD2*, Smita Bhatia, MD, MPH4 and Smith Giri4*

1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
2Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
3University of Alabama at Birmingham, Birimingham, AL
4University of Alabama at Birmingham, Birmingham, AL
5Department of Surgery, University of Alabama at Birmingham, Birmingham, AL

Nora Balas, PhD1*, Joshua Richman2*, Wendy Landier, PhD3*, Sadeep Shrestha, PhD4*, Katia J Bruxvoort, PhD5*, Lindsey Hageman, MPH1*, Qingrui Meng, MS3*, Elizabeth Ross5*, Alysia Bosworth, BA6*, Hok Sreng Te7*, F. Lennie Wong, PhD8, Ravi Bhatia, MD9, Stephen J. Forman, MD, FACP10, Saro Armenian, DO, MPH6, Daniel Weisdorf, MD7 and Smita Bhatia, MD, MPH1

1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
2Department of Surgery, University of Alabama at Birmingham, Birmingham, AL
3University of Alabama At Birmingham, Birmingham, AL
4School of Public Health, University of Alabama at Birmingham, Birmingham, AL
5University of Alabama at Birmingham, Birmingham, AL
6City of Hope National Medical Center, Duarte, CA
7University of Minnesota, Minneapolis, MN
8City of Hope, Duarte, CA
9Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
10Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA

Betty Gration, BMBCh, MRCP, BSc, M.Bioch1*, Cameron Wellard, BSc (Hons), PhD2*, Elizabeth Moore, PhD, MPH, PgradDip (Nurs Crit Care)2*, Peter Mollee, FRACP, MBBS, MSc, FRCPA3, Ian H. Kerridge, FRACP, FRCPA, MPhil, BA4*, Andrew Spencer, MBBS5,6*, Anita Shetty, MD7*, Bart Baker8*, Cecily Forsyth, MD9, Jessica Heenan, MBBS, FRACP, FRCPA10*, Zoe K McQuilten, MBBS, PhD11, Erica M. Wood, MD11,12 and Georgia McCaughan, BMedSc MBBS MMed (Clin Epi) FRACP FRCPA1*

1Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, Australia
2School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia
3Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia
4Royal North Shore Hospital, Sydney, Australia
5Department of Malignant Haematology & Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia
6School of Translational Medicine, Alfred Health-Monash University, Melbourne, VIC, Australia
7Nepean Hospital, Penrith, Australia
8Palmerston North Hospital, Palmerston North, New Zealand
9Central Coast Local Health District (Gosford and Wyong Hospitals), Gosford, Australia
10Department of Haematology, Holman Clinic, Launceston General Hospital, Tasmania, Australia, Launceston, TAS, Australia
11Department of Haematology, Monash Health, Melbourne, Australia
12Monash University, Melbourne, Australia

Maria Queralt Salas, MD, PhD1*, Maria Teresa Solano2*, Mónica Baile González, MD3*, Marina Acera Gómez3*, Maria Laura Fox, MD4*, Maria del Mar Pérez Artigas4*, Ana Santamaria, MD5*, María del Carmen Quintela González5*, Andres Sanchez Salinas, MD6*, Joaquina Salmeron Camacho7*, Veronica Illana Álvaro8*, Zahra Abdallahi Lefdil8*, Sara Fernandez-Luis, MD9*, Leddy Patricia Vega Suárez9*, Javier Cornago, MD10*, Laura Pardo, MD10*, Sara Villar, MD11*, Patricia Beorlegui Murillo12*, Albert Esquirol, MD13*, Isabel Izquierdo, MD14*, Sonia González Rodriguez15*, Alberto Mussetti, MD16*, Aitor Abuin Blanco, MD17*, Silvia Filafferro18*, Pascual Balsalobre19*, Leyre Bento De Miguel20* and Ana Maria Sureda Balari, MD, PhD21

1Hematopoietic Transplantation Unit, Hospital Clinic de Barcelona, ICAMS, Barcelona, Spain
2Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICAMS, Barcelona, Spain
3Servicio de Hematología y Hemoterapia del Complejo Asistencial Universitario de Salamanca -IBSAL, Salamanca, Spain
4Vall d'Hebron University Hospital, Barcelona, Spain
5Hospital Álvaro Cunqueiro, Vigo, Spain
6Hematology Department, Hospital Universitario Virgen de la Arrixaca., Murcia, Spain
7Hospital Universitario Virgen de la Arrixaca., Murcia, Spain
8Hospital Universitario de la Princesa, Madrid, Spain
9Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
10Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
11Hematology and Cell Therapy Department. Clinica Universidad de Navarra. IdiSNA., Pamplona, Spain
12Hematology and Cell Therapy Department, Clinica Universidad de Navarra, Navarra, Spain
13Hematology and Hemotherapy Department, Hospital de la Sant Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Universitat Autónoma de Barcelona, Barcelona, Spain
14Hospital Universitario Miguel Servet, Zaragoza, Spain
15Institut Catala d’Oncologia-Hospitalet, Clinical Hematology Department, Barcelona, Spain
16Clinical Hematology Department, Institut Catala d’Oncologia-Hospitalet, L'Hospitalet De Llobregat, Barcelona, Spain
17University Hospital of Santiago De Compostela, SANTIAGO DE COMPOSTELA, ESP
18Grupo EspañOl De Trasplante De Progenitores HematopoyéTicos Y Tera, Madrid, ESP
19Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular (GETH-TC), Madrid, AL, Spain
20Hematology Department, Son Espases University Hospital, IdISBa, Palma De Mallorca, Spain
21Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain

Binoy Yohannan, MD1,2, Angela Dispenzieri, MD1, Francis Buadi, MD1, David Dingli, MD, PhD1, Nelson Leung, MD1, Prashant Kapoor, MD3, Wilson I. Gonsalves, MD4, Taxiarchis Kourelis, MD1, Joselle Cook, MBBS1, Moritz Binder, MD1, Suzanne R Hayman, MD1, Yi Lin, MD, PhD1, Ronald S Go, M.D.1, Rahma M Warsame, MD1, Vincent Rajkumar, MD1*, Shaji Kumar, MD1, Eli Muchtar, MD1, Hassan B Alkhateeb, MD1*, William J. Hogan, MD1, Mark R. Litzow, MD1, Mrinal M. Patnaik, MD, MBBS3, Aref Al-Kali, MD1, Abhishek Mangaonkar, MD5*, Robert C Wolf, Pharm.D, R.Ph.6*, Mithun V Shah, M.D., Ph.D.1 and Morie A. Gertz, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
3Mayo Clinic, Rochester, MN
4Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
5Division of Hematology, Mayo clinic, Rochester, MN
6Department of Pharmacy, Mayo Clinic, Rochester, MN

Sandra CM Quinn, PhD, BA1* and Danielle Romaniuk2*

1Research and Advocacy, Myeloma UK, Edinburgh, SCO, United Kingdom
2Research and Advocacy, Myeloma UK, Edinburgh, Scotland, United Kingdom

Smith Giri1*, Liton Francisco1*, Nicole Rafalko2,3*, Niodita Gupta-Werner3*, Joshua Richman4*, Smita Bhatia, MD, MPH5, Kelly Godby1*, Gayathri Ravi, MD1, Susan Bal, MD1*, Marjohn Armoon, PharmD6*, Rohan Medhekar3* and Luciano J. Costa, MD, PhD1

1Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
2Drexel University, Philadelphia, PA
3Janssen Scientific Affairs, LLC, Horsham, PA
4Department of Surgery, University of Alabama at Birmingham, Birmingham, AL
5Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
6Medical Director, Multiple Myeloma, Hematology US Medical Affairs, Johnson & Johnson, Horsham, PA

Craig C. Hofmeister, MD1, Mingyuan Zhang, MS2*, Vikas A. Gupta, MD PhD3, Nisha S. Joseph, MD3, Jonathan L. Kaufman, MD3, Ajay K. Nooka, MD, MPH4, Madhav V. Dhodapkar, MD PhD3, Sagar Lonial, MD3* and Douglas W. Sborov, MD, MS5

1Emory Digital, Emory University, Atlanta, GA
2Data Science Service, University of Utah, Salt Lake City, UT
3Winship Cancer Institute of Emory University, Atlanta, GA
4Winship Cancer Institute of Emory University, Atlanta
5Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT

Carmine Liberatore1*, Paola Tacchetti, MD, PhD2*, Concetta Conticello, MD3*, Gregorio Barila4*, Elisabetta Antonioli5*, Angelo Belotti, MD6*, Anna Maria Cafro, MD7*, Laura Paris, MD8*, Velia Bongarzoni9*, Massimo Gentile, MD10*, Matteo DA VIA, MD11*, Barbara Gamberi, MD12*, Sara Pezzatti13*, Fabrizio Ciambelli, MD14*, Mariagrazia Garzia15*, Ombretta Annibali, MD16*, Francesca Fazio17*, Giusy Antolino18*, Nicola Sgherza19*, Francesca Farina20*, Annalisa Citro21*, Monica Galli22*, Vittorio Del Fabro23*, Claudio Salvatore Cartia, MD24*, Francesca Fioritoni25*, Katia Mancuso, MD, PhD2,26*, Irene Attucci27*, Maria Luisa Pioltelli28*, Michele Puppi, MD29*, Sofia Terlizzi30*, Chiara Lisi31*, Virginia Valeria Ferretti32*, Massimo Offidani, MD 33*, Maria Teresa Petrucci, MD31* and Silvia Mangiacavalli, MD24*

1Hematology Unit, Department of Oncology and Hematology,, Ospedale Santo Spirito, Pescara, ITA
2Istituto di Ematologia “Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
3AOU Policlinico G. Rodolico-San Marco, University School of Medicine, Catania, Italy, Catania, ITA
4Hematology Unit, Ospedale San Bortolo, Vicenza, Italy
5Careggi Hospital and University of Florence, Firenze, Italy
6Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
7Department of Hematology, GOM Niguarda Hospital, Milan, Milan, ITA
8Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
9Department of Hematology, San Giovanni-Addolorata Hospital, ROMA, ITA
10Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy, Cosenza, Italy
11Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
12Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy
13Department of Hematology and Transplantation, Azienda Socio Sanitaria Territoriale di Monza ASST-Monza, St Gerardo Hospital, Monza, Italy
14SC Ematologia, ASST Valle Olona - Ospedale di Circolo, Busto Arsizio, Italy
15Azienda Ospedaliera San Camillo Forlanini, UOC Hematology and stem cell transplant, Roma, ITA
16Division of Hematology, Stem Cell Transplantation,, Fondazione Policlinico Universitario Campus Bio Medico, Roma, Italy
17Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, ROMA, Italy
18Multiple Myeloma GIMEMA Lazio Group, rome, ITA
19Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine, Bari, Italy
20Hematology and BMT unit, IRCCS Ospedale San Raffaele, Milano, Italy
21UOC Ematologia, Ospedale Civile di Legnano, Legnano, Italy
22Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
23Division of Hematology, Azienda Policlinico-S. Marco, University of Catania, Catania, ITA
24Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
25Department of Haematology, Pescara, ITA
26Department of Medical and Surgical Science, DIMEC, University of Bologna, Bologna, ITA
27Careggi University Hospital, florence, Italy
28Department of Hematology, GOM Niguarda Hospital, Milan, ITA
29Istituto di Ematologia "Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
30Department of Hematology, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy
31Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Roma, Italy
32Unit of Biostatistics and Clinical Trial Center, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
33Clinica di Ematologia Ospedali Riuniti Ancona, Ancona, Italy

Frances N. Cervoni Curet, MD1*, Roland L. Bassett, MS2*, Oren Pasvolsky, MD3, Abdullah Faisal Deen1*, Mark R. Tanner, PhD1*, Qaiser Bashir, MD1, Samer A. Srour, MD1, Neeraj Y. Saini, MD1, Jeremy Ramdial, MD1, Yago Nieto, MD, PhD1, Hans C. Lee, MD3, Krina K. Patel, MD, MSc3, Partow Kebriaei, MD1, Warren B. Fingrut, MD1*, Portia Smallbone, MD1*, Melody R. Becnel, MD3, Mahmoud R. Gaballa, MD3, Sheeba K. Thomas, MD3, J Christine Ye, MD3*, Robert Z. Orlowski, MD, PhD3, Richard E. Champlin, MD1, Elizabeth J. Shpall, MD1 and Muzaffar H. Qazilbash, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Andrea Tufano-Sugarman, MD1, Shahidul Islam, DrPH, MPH, PStat2*, Faith E Davies, MD3, Gareth Morgan, M.D., Ph.D.4*, David Kaminetzky, MD4*, Oscar B Lahoud, MD5 and Marc J Braunstein, MD, PhD6

1NYU Perlmutter Cancer Center, NYU Grossman Long Island School of Medicine, Mineola, NY
2Biostatistics Unit, Office of Academic Affairs, Northwell Health, New Hyde Park, NY
3NYU Perlmutter Cancer Center, NYU Langone Health, New York, NY
4NYU Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY
5NYU Perlmutter Cancer Center, NYU Grossman School of Medicine, Brooklyn, NY
6NYU Perlmutter Cancer Center, NYU Grossman Long Island School of Medicine, Great Neck, NY

Martin Stork1*, Jakub Radocha, MD, PhD2*, Tomas Jelinek, MD, PhD3*, Ivan Spicka, CSc4*, Tomas Pika5*, Alexandra Jungova6*, Jan Straub7*, Jiri Minarik8, Ivanna Boichuk9*, Dominik Fric9*, Denisa Novakova2*, Tereza Popkova, MD10*, Lenka Polcerova11*, Vladimir Maisnar, MD, PhD12*, Ludek Pour, PhD1* and Roman Hajek, MD, PhD13

1Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
24th Department of Internal Medicine – Hematology, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University Czech Republic, Hradec Kralove, Czech Republic
3Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic
41st Medical Department – Clinical Department of Hematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic, Prague, Czech Republic
5Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
6Hematology and Oncology Department, Charles University Hospital Pilsen, Pilsen, Czech Republic
71st Medical Department – Clinical Department of Haematology, First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic
8Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic, Olomouc, Czech Republic
9Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic, Brno, Czech Republic
10Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic
11Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic, Brno, Czech Republic
124th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
13University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic

Cesar Rodriguez, MD1*, Hsien-Yen Chang, PhD2*, Yi-Hsuan Liu, PhD, MS, RD2*, Jinghua He2*, Hoa H. Le, PhD2*, Jessica Maitland3*, Alvi A. Rahman3*, Anabelle Tardif-Samson3*, Bronwyn Moore3*, Marie-Hélène Lafeuille, MA3*, Saurabh N. Patel, MD2* and Xinke Zhang, PhD2*

1Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Johnson & Johnson Innovative Medicine, Horsham, PA
3Analysis Group, Inc., Montreal, QC, Canada

Esraa Abdalla, PharmD1*, Malak Alharbi, MBBS1*, Sawyer Bawek, DO2, Catherine Forbes, PharmD1*, Ian Lund, PA-C1*, Han Yu, PharmD, MS, MA1*, Berthliz Durand, Pharmacy Candidate2*, Jens Hillengass, MD, PhD3, Hamza Hassan, MD1* and Eugene Przespolewski, PharmD1*

1Roswell Park Comprehensive Cancer Center, Buffalo, NY
2University at Buffalo, Buffalo, NY
3Department of Medicine - Myeloma, Roswell Park, Buffalo, NY

Wenjing Wang, MD1,2*, Jing Li, MD1*, Mengyuan Li3,4*, Xiao He5*, LI Bao6*, Xiaoqiong Tang7*, Hua Xue8*, Jianmei Xu8*, Liye Zhong, MD, PhD9* and Peng Liu, MD1,2

1Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China
2Department of Hematology, Shanghai Geriatric Medical Center, Shanghai, China
3School of Medicine South China University of Technology, Guangzhou, China
4Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
5Department of Hematology, Xiangya Hospital, Central South University, Changsha, China
6Beijing Jishuitan Hospital, Beijing, Beijing, CHN
7Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
8Affiliated Hospital of Hebei University, Baoding, China
9Department of Haematology, The First Affiliated Hospital of JINAN University, Guangzhou, China

Amna Gul, MD1*, Yumna Afaq, MBBS2*, Talha Khan, MBBS3*, Mahnoor Asghar Keen, MD, MBBS3*, Shayan Ahmad, MBBS3*, Mahd Aftab Khan, MD4*, Rida Hussain, MD5*, Arslan Inayat, MD6*, Danish Safi, MD7 and Salahuddin Safi, MD8*

1Miami Cancer Institute, Miami, FL
2Khyber Medical College, Peshawar
3Khyber Medical College, Peshawar, Pakistan
4West Virginia University, Morgantown, WV
5Camden Clark Medical Center, Parkersburg, WV
6HSHS St.Mary's Hospital, Decatur
7Department of Medical Oncology, West Virginia University Cancer Institute, Morgantown, WV
8West Virginia University Cancer Institute, Morgantown, WV

Gabriela A Abreu, PhD1*, Juliana Queiroz1*, Thiago Luiz Nogueira da Silva1*, Claudia R Soares1*, Patricia Menezes1*, Mariano Carrizo2*, Tatiana Ricca1*, Tatiana Pires1*, Straus Tanaka1*, Lucas Perelli2*, Graziela Bernardino1*, André Luiz Alves Ribeiro de Souza3*, Ventura Simonovich4*, Paula Scibona5*, Cristian M Seehaus6*, Erika B Brulc6,7*, Natalia Kim8* and Laura Jotimliansky9*

1GSK, Rio de Janeiro, Brazil
2GSK, Buenos Aires, Argentina
3Orizon (at the time of data acquisition), São Paulo, Brazil
4Oncological Gynecology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
5Clinical Pharmacology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
6Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
7Hematology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
8GSK, London, United Kingdom
9GSK (at the time of data acquisition), Buenos Aires, Argentina

Michael Weise, PharmD1,2*, Shebli Atrash, MD2,3, Briha Ansari4*, Muhammad Umair Mushtaq2,5, Joseph P. McGuirk, DO5, Al-Ola Abdallah, MD2,5, Zahra Mahmoudjafari, PharmD2,5* and Nausheen Ahmed, MD2,6

1Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS
2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
3Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
4Johns Hopkins University, Baltimore
5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
6University of Kansas Cancer Center, Kansas City, KS

Fathima Shehnaz Ayoobkhan, MD1,2, Raabia Qureshi3,4*, Raeef L Rahman, BS5,6, Zohaa Faiz3*, Sohaib Irfan, MD3*, Ahmad Iftikhar, MD7*, Briha Ansari8*, Muhammad Umair Mushtaq, MD5,9, Al-Ola Abdallah, MD5,10, Shahzad Raza, MD11, Hira Shaikh, MD5,12, Forat Lutfi, MD5,13, Shebli Atrash, MD5,14, Joseph P. McGuirk, DO5,15, Hamza Sloan Hashmi, MD16,17*, Faiz Anwer, MD5,11 and Nausheen Ahmed, MD5,18

1U.S. Myeloma Innovations Research Collaborative., kansas
2Trinity Health Oakland, Pontiac, MI
3U.S. Myeloma Innovations Research Collaborative., Kansas
4University of Missouri Medical Center, Kansas
5US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
6School of Medicine, University of Kansas Medical Center, Kansas City, KS
7University of Arizona, Tucson, AZ
8Johns Hopkins University, Baltimore
9Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Overland Park, KS
10University of Kansas Cancer Center, Fairway, KS
11Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
12University of Iowa Caver College of Medicine, Coralville, IA
13University of Kansas Medical Center, Westwood, KS
14Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
15Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Ctr., Westwood, KS
16Myeloma Service, Department of Medicine, Memorial Sloan Kettering, New York, NY
17US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, NY
18University of Kansas Cancer Center, Kansas City, KS

Maria-Victoria Mateos, MD, PhD1, Fernando Escalante2*, Natalia Marin Huarte3*, Angela Garcia Garcia-Porrero3*, Miguel Jesús Villanueva Forero, MD3, Rafael Rios Tamayo, MD, PhD4*, Antonia Sampol Mayol, MD5*, Eugenio Gimenez6*, Jose-Angel Hernandez Rivas, MD, PhD7*, Savana Research Group8* and Joaquin Martinez Lopez, PhD, MD9*

1University Hospital of Salamanca, Salamanca, Spain
2Complejo Asistencial Universitario de León, León, Spain
3Janssen-Cilag, S.A., Madrid, ESP
4Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, ESP
5Hematology Department., Hospital Universitario Son Espases, IdISBa., Palma, Spain
6Hospital Universitario Infanta Sofía, Madrid, Spain
7Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain
8Savana Reseach, Madrid, Spain
9Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain

Carina E. Ferraris1*, Xiaoyin Li2*, Gabriel De Avila3*, Lisa M. Gudenkauf4*, Aasha I. Hoogland2*, Oanh Nguyen4*, Yvelise Rodriguez2*, Sylvia L. Crowder4*, Nathan Parker, PhD, MPH2*, Tiffany L. Carson4*, Rachid C. Baz5, Kenneth H. Shain, MD, PhD6, Brandon Blue3, Ariel Grajales-Cruz, MD7, Melissa Alsina, MD7, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP8, Omar Castaneda, MD8, Taiga Nishihori, MD9, Hien Liu, MD7, Frederick L. Locke, MD10, Heather S.L. Jim, PhD2*, Doris K. Hansen, MD8, Lauren C. Peres, PhD, MPH11* and Laura B. Oswald, PhD2*

1College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale
2Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL
3H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa
5Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
6H. Lee Moffitt Cancer Center, Tampa, FL
7Moffitt Cancer Center, Tampa, FL
8Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
9Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
10Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
11Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL

Carlyn Rose Tan, MD1, Sireesha Asoori, MBBS, MPH2*, David Nemirovsky3*, Andriy Derkach, PhD3*, Larissa Brunaldi4*, Rakesh Popat5, Chris Lau5*, Efstathios Kastritis, MD6*, Joaquín Martínez-Lopez7*, Radhika Bansal, MBBS4*, Andre De Menezes Silva Corraes, MD4*, Saurabh Chhabra, MD8, Ricardo D. Parrondo, MD9, Sikander Ailawadhi10, Despina Fotiou, MD11*, Meletios Dimopoulos, MD11, Kwee Yong, MD, PhD5, Catriona Mactier, MD5*, Magdalena Corona7*, Adolfo Jesús Sáez Marín, MD7*, Hira Mian, MD12, Saad Z. Usmani, MD13, Brian G.M. Durie14, Thomas G. Martin, MD15 and Yi Lin, MD, PhD16

1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2University of California, San Francisco, CA
3Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
4Mayo Clinic Cancer Center, Rochester, MN
5Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
6Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Voula,Athens, AL, Greece
7University of Complutense, Hospital 12 de Octubre, Madrid, Spain
8Division of Hematology, Mayo Clinic, Phoenix, AZ
9Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
10Division of Hematology, Mayo Clinic, Jacksonville, FL
11Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
12McMaster University, Hamilton, ON, Canada
13Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
14International Myeloma Foundation, Studio City, CA
15University of California, San Francisco, San Francisco, CA
16Division of Hematology, Mayo Clinic, Rochester, MN

Diana Basali, MD1, Heather McKee Hurwitz, PhD2*, Kim Bell, MBA, RN, BSN2*, Kimberly Sanders, BA2*, Mark Ribbins, BA2*, Raymond Jackson, BA2* and Jason Valent, MD3

1Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Pepper Pike, OH
2Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Omar Castaneda, MD1, Doris K. Hansen, MD2, Mariola A Vazquez-Martinez, MD1, Shrikar Modukuri3*, Brandon Blue4, Julia Fadul, PharmD5*, Ariel Denson, PharmD6*, Parker Melnick, BS5*, Filip Ionescu, MD, MS3, Kristy Harvey5*, Blanca Lopez3*, Katherine Tobon, PharmD, BS7*, Hien Liu, MD3, Jose L. Ochoa-Bayona, MD3*, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP8, Taiga Nishihori, MD3, Kenneth H. Shain, MD, PhD9, Rachid Baz, MD10, Melissa Alsina, MD3, Ariel Grajales-Cruz, MD3, Allison Graeter, MD11 and Frederick Locke, MD12

1H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2H. Lee Moffitt Cancer Center & Research Institute, Tampa
3Moffitt Cancer Center, Tampa, FL
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Moffitt Cancer Center, Tampa
6Department of Pharmacy, Moffitt Cancer Center, Tampa, FL
7Department of Pharmacy, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
9H. Lee Moffitt Cancer Center, Tampa, FL
10Moffitt cancer center and research institute, tampa, FL
11University of South Florida, Tampa, FL
12Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Maya D. Srinivasan, MD, MSc1,2, John Culnan, PhD3*, Mehar Hora, BS1*, Alexander Lazzaro, MD1,2*, Britney Bell, MD1,2, Geethika Bodanapu, BA1, Cenk Yildirim, MS3,4*, June Corrigan, MS3*, Nhan V. Do, MD, MS1,3*, Mary T. Brophy, MD1,3*, Nikhil C. Munshi, MD3,5,6, Raphael E. Szalat, MD, PhD1,2, Nathanael R. Fillmore, PhD2,3,6* and Camille V. Edwards, MD1,2

1Boston University Chobanian & Avedisian School of Medicine, Boston, MA
2Section of Hematology and Medical Oncology, Boston Medical Center, Boston, MA
3VA Boston Healthcare System, Boston, MA
4Massachusetts Veterans Epidemiology Research and Information Center, Boston
5Dana-Farber Cancer Institute, The Jerome Lipper Multiple Myeloma Center, Boston, MA
6Harvard Medical School, Boston, MA

Haiqiong Zheng1*, Shi Han, PhD2*, Houli Zhao2*, Yongxian Hu3* and He Huang, MD4*

1Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China, AL, China
2Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
3Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
4Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, hangzhou, China

Rahul Banerjee, MD, FACP1, Hsien-Yen Chang, PhD2*, Yi-Hsuan Liu, PhD, MS, RD2*, Hoa H. Le, PhD2*, Helen Pai, MS2*, Saurabh N. Patel, MD2* and Xinke Zhang, PhD2*

1Fred Hutchinson Cancer Center, Seattle, WA
2Johnson & Johnson Innovative Medicine, Horsham, PA

Alissa Visram, MD, MPH1, Rajshekhar Chakraborty, MD2, Gregory R Pond, PhD3*, Hsien Seow4*, Anastasia Gayowsky5*, Ghulam Rehman Mohyuddin, MD6, Samer Al Hadidi, MD, MSc7, Alejandro Garcia-Horton8*, Rafael Fonseca, MD9 and Hira Mian, MD10

1Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
2Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
3Department of Oncology, McMaster University, Hamilton, Canada
4Department of Oncology, McMaster University, Hamilton, ON, Canada
5Institute for Clinical Evaluative Sciences, McMaster University, Hamilton, ON, Canada
6Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
7University of Arkansas for Medical Sciences, Little Rock, AR
8McMaster University, Hamilton, ON, CAN
9Division of Hematology, Mayo Clinic, Paradise Valley, AZ
10McMaster University, Hamilton, ON, Canada

Hira Shaikh, MD1,2, Jonathan Lochner, PharmD3*, Bradley Loeffler4*, Reed Friend, MD2,5, Alma Habib, MD2,6, Marshall McKenna, MD2,7*, Jordan Snyder, PharmD2,8*, James A Davis, PharmD2,9*, Gina Patrus2,10*, Rachel Dileo2,11*, Prerna Mewawalla12,13*, Kimberly M Green, DO2,9*, Muhammad Umair Mushtaq, MD2,8, Christopher Strouse, MD2,14, Yun Kyoung Tiger, MD, PhD2,7, Al-Ola Abdallah, MD2,15, Nausheen Ahmed, MD2,16, Abdullah Mohammad Khan, MD, MBBS2,6, Hamza Sloan Hashmi, MD9,17,18*, Barry Paul, MD, MS2,5 and Shebli Atrash2,19*

1Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Coralville, IA
2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
3Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
4Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA
5Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
6Division of Hematology, The Ohio State University, Columbus, OH
7Division of Hematology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
8Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Overland Park, KS
9Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
10Division of Hematology and Cellular Therapy, Allegheny Health Network, Pittsburgh, PA
11Allegheny Health Network Research Institute, Cranberry Twp, PA
12Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA
13US Myeloma Innovations Research Collaborative (USMIRC), kansas city, KS
14Division of Hematology, Oncology, and Blood & Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA
15Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
16Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
17Myeloma Service, Department of Medicine, Memorial Sloan Kettering, New York, NY
18US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, NY
19Levine Cancer, Atrium Health, Wake Forest University School of Medicine, Charlotte, NC

Mehndi Dandwani, MBBS1, Aliya Rashid, DO, MPH2,3, Donald C Moore, PharmD, BCPS, BCOP, DPLA, FCCP4*, Julia Balmaceda, MD5*, Belal Abousaida, MD, PhD5*, Aishwarya Sannareddy, MBBS6*, Paige Laverick7*, Prerna Rastogi, MD, PhD8*, Abdullah Thayyil8*, James A Davis, PharmD2,9*, Kimberly M Green, DO2,9*, Christopher Strouse, MD2,10, Aimaz Afrough2,6*, Barry Paul, MD, MS2,4, Hamza Sloan Hashmi, MD9,11,12*, Larry D Anderson Jr., MD, PhD6, Nausheen Ahmed, MD2,13, Al-Ola Abdallah, MD2,14, Shebli Atrash2,15* and Hira Shaikh, MD2,10

1University of Iowa Healthcare, Iowa, IA
2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, KS
4Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
5University of Kansas Medical Center, Kansas City
6Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
7Medical University of South Carolina, Charleston, SC
8University of Iowa Healthcare, Iowa City, IA
9Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
10Division of Hematology, Oncology, and Blood & Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA
11Myeloma Service, Department of Medicine, Memorial Sloan Kettering, New York, NY
12US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, NY
13Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
14Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
15Levine Cancer, Atrium Health, Wake Forest University School of Medicine, Charlotte, NC

Muhammad Salman Faisal, MD, MBBS1, Muhammad Talha Shaukat2*, Wania Ur Rehman2*, Mariam Shahabi3*, Muhammad Shahzaib2*, Ali Mohsin4*, Zunaira Amjad5*, Aqeeb Ur Rehman6*, Zainab Sajjad2*, Aleenah Mohsin7*, Shammas Bajwa, MD8* and Silas Day, MS9*

1University of Oklahoma Stephenson Cancer Center, Oklahoma City, OK
2King Edward Medical University, Lahore, Pakistan
3Dow University of Health Sciences, Karachi, Pakistan
4Shalamar Medical and Dental College, Lahore, Pakistan
5Services Institute of Medical Sciences, Lahore, Pakistan
6University of Alabama at Birmingham, Birmingham, AL
7Brown University, Providence, RI
8Internal Medicine Department, Oklahoma University Medical Center, Oklahoma City, OK
9Hematology/Oncology Clinical Trials Office, OU Health Stephenson Cancer Center, Oklahoma City, OK

Henry Becerra, MD1, Mustafa Wasifuddin, MD1*, Ifeanyi Nnamdi Uche, MBBS2, Nosakhare Paul Ilerhunmwuwa, MBBS, MSc3, Narek Hakobyan, MD1, Dosbai Saparov, MD1*, Shakirat Gold-Olufadi, MBBS4, Philipp Barakat, MD5*, Ayesha Nayab Nasir, MD5*, Victor Sebastian Arruarana, MD5*, Neharika Shrestha, MBBS5, Omid Heravi, MD6, Beka Aroshidze, MD6, Hesham Abowali, MD6*, Ruchi Yadav, MD6, Akriti Pokhrel, MBBS6*, Jin Zheng, MD, PhD6, Muhammad Tahir, MD7*, Pei-Ting Chen, MD5*, Amulya Bellamkonda, MD7* and Jen-Chin Wang, MD8

1Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY
2Department of Medicine, One Brookdale University Hospital and Medical Center, Brooklyn, NY
3Department of Hematology, University of Pittsburgh Medical Center, Brooklyn, NY
4Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY
5Brookdale University Hospital and Medical Center, Brooklyn, NY
6Division of Hematology/Oncology, Brookdale University Hospital and Medical Center, Brooklyn, NY
7Hematology and Oncology, Brookdale University Hospital and Medical Center, Brooklyn, NY
8Division of Hematology/Oncology, Brookdale University Hospital and Medical Center, Long Beach, NY

Beth M. Faiman, PhD, CNP1, Louis S Williams, MD1, Jack Khouri, MD2, Faiz Anwer, MD2, Shahzad Raza, MD2,3, Christy J. Samaras, DO2, Kimberly Hamilton, CNP4*, Cynthia Scott, CNP1*, Saveta Mathur, CNP3*, Omer N. Koc, MD5, Willem J. van Heeckeren, MD6, Jason Valent, MD2 and Sandra Mazzoni, DO7

1Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
3Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
4Cleveland Clinic Taussig Cancer Institute, CLEVELAND, OH
5Cleveland Clinic Foundation, Beachwood, OH
6Taussig Cancer Institute, Cleveland Clinic, Mayfield Heights, OH
7Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH

*signifies non-member of ASH